HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Promacyl

HCID 36733
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
34264-24-9
Standard SMILES
CCCC(=O)CNC(=O)Oc1cc(C)cc(C(C)C)c1
InChIKey
GGRLUNQHANDPSC-UHFFFAOYSA-N
Molecular formula
C16H23NO3
Average molar mass
277.36 g/mol
Monoisotopic mass
277.1677936

Overview

Promacyl is an alkylbenzene.

Names & identifiers

Preferred name
Promacyl
IUPAC
(3-methyl-5-propan-2-ylphenyl) N-(2-oxopentyl)carbamate
English name
(3-methyl-5-propan-2-yl-phenyl) N-(2-oxopentyl)carbamate
Molecular formula
C16H23NO3
Molecular weight
277.36

Names & synonyms

PromacylPromicide34264-24-9AL7FSR8UNPCRC 7320Butyrylmethyl carbamic acid m-cym-5-yl esterBRN 21459815-Methyl-m-cumenyl butyryl(methyl)carbamateCARBAMIC ACID, BUTYRYLMETHYL-, m-CYM-5-YL ESTER5-Methyl-m-cumenyl butyryl (methyl)carbamatem-Cym-5-yl butyrylmethyl carbamateUNII-AL7FSR8UNP
Show more names
(3-methyl-5-propan-2-yl-phenyl) N-(2-oxopentyl)carbamate(1-Oxobutyl)methylcarbamic acid 3-isopropyl-5-methylphenyl esterCarbamic acid, N-methyl-N-(1-oxobutyl)-, 3-methyl-5-(1-methylethyl)phenyl ester
Carbamic acid, methyl(1-oxobutyl)-, 3-methyl-5-(1-methylethyl)phenyl ester3-Methyl-5-(1-methylethyl)phenyl methyl(1-oxobutyl)carbamatem-Cym-5-yl butyrylmethyl carbamate (8CI)RefChem:176226DTXCID70318283-Methyl-5-(1-methylethyl)phenyl methyl(1-oxobutyl)carbamate (9CI)3-methyl-5-(propan-2-yl)phenyl N-(2-oxopentyl)carbamateCarbamic acid, methyl(1-oxobutyl)-, 3-methyl-5-(1-methylethyl)phenyl ester (9CI)

Database identifiers

CAS
34264-24-9

Properties

Computed structural properties

XLogP
3.7
Topological polar surface area
55.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
7
Heavy atoms
20
Formal charge
0
Complexity
328

Physicochemical properties

Boiling point
362.2 · 362.2±52.0 °C(Predicted)
Density
1.051 · 1.051±0.06 g/cm3(Predicted)
pka
-2.4 · -2.40±0.70(Predicted)
FDA UNII
7 FSR8UNP · AL7FSR8UNP

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Hazard information

Other Safety InformationIMAP assessments - Carbamic acid, methyl(1-oxobutyl)-, 3-methyl-5-(1-methylethyl)phenyl ester: Environment tier I assessment

Toxicology

Treatment · 1 item

If the compound has been ingested, rapid gastric lavage should be performed using 5% sodium bicarbonate. For skin contact, the skin should be washed with soap and water. If the compound has entered the eyes, they should be washed with large quantities of isotonic saline or water. In serious cases, atropine and/or pralidoxime should be administered. Anti-cholinergic drugs work to counteract the effects of excess acetylcholine and reactivate AChE. Atropine can be used as an antidote in conjunction with pralidoxime or other pyridinium oximes (such as trimedoxime or obidoxime), though the use of '-oximes' has been found to be of no benefit, or possibly harmful, in at least two meta-analyses. Atropine is a muscarinic antagonist, and thus blocks the action of acetylcholine peripherally.

Health Effects · 1 item

Acute exposure to cholinesterase inhibitors can cause a cholinergic crisis characterized by severe nausea/vomiting, salivation, sweating, bradycardia, hypotension, collapse, and convulsions. Increasing muscle weakness is a possibility and may result in death if respiratory muscles are involved. Accumulation of ACh at motor nerves causes overstimulation of nicotinic expression at the neuromuscular junction. When this occurs symptoms such as muscle weakness, fatigue, muscle cramps, fasciculation, and paralysis can be seen. When there is an accumulation of ACh at autonomic ganglia this causes overstimulation of nicotinic expression in the sympathetic system. Symptoms associated with this are hypertension, and hypoglycemia. Overstimulation of nicotinic acetylcholine receptors in the central nervous system, due to accumulation of ACh, results in anxiety, headache, convulsions, ataxia, depression of respiration and circulation, tremor, general weakness, and potentially coma. When there is expression of muscarinic overstimulation due to excess acetylcholine at muscarinic acetylcholine receptors symptoms of visual disturbances, tightness in chest, wheezing due to bronchoconstriction, increased bronchial secretions, increased salivation, lacrimation, sweating, peristalsis, and urination can occur. Chronically high (>10 years) exposure leads to neuropsychological consequences including disturbances in perception and visuo-motor processing (A15321).

Chemistry & industry

Pharmacology

Metabolism/MetabolitesThe carbamates are hydrolyzed enzymatically by the liver; degradation products are excreted by the kidneys and the liver. (L793)

Uses & manufacturing

UsesPromacyl is widely used as an insecticide or pesticide in homes, gardens and agricultural applications. It is a synthetic compound.

Applications

UsesPromicide is a pesticide.

Suppliers2 total

TargetMol 中国(陶术生物)400-821-0310 15002144251 · [email protected]
上海杰股生物科技有限公司021-51698675 · [email protected]

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
36733
ChEBI
CHEBI:82095
UNII
AL7FSR8UNP
Exposure RoutesInhalation (L793) ; oral (L793); dermal (L793)
Toxicity Summary · 1 item

Promacyl is a cholinesterase or acetylcholinesterase (AChE) inhibitor. Carbamates form unstable complexes with chlolinesterases by carbamoylation of the active sites of the enzymes. This inhibition is reversible. A cholinesterase inhibitor suppresses the action of acetylcholine esterase. Because of its essential function, chemicals that interfere with the action of acetylcholine esterase are potent neurotoxins, causing excessive salivation and eye-watering in low doses. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Acetylcholine esterase breaks down the neurotransmitter acetylcholine, which is released at nerve and muscle junctions, in order to allow the muscle or organ to relax. The result of acetylcholine esterase inhibition is that acetylcholine builds up and continues to act so that any nerve impulses are continually transmitted and muscle contractions do not stop.

Signs and Symptoms · 1 item

As with organophosphates, the signs and symptoms are based on excessive cholinergic stimulation. Unlike organophosphate poisoning, carbamate poisonings tend to be of shorter duration because the inhibition of nervous tissue acetylcholinesterase is reversible, and carbamates are more rapidly metabolized. Muscle weakness, dizziness, sweating and slight body discomfort are commonly reported early symptoms. Headache, salivation, nausea, vomiting, abdominal pain and diarrhea are often prominent at higher levels of exposure. Contraction of the pupils with blurred vision, incoordination, muscle twitching and slurred speech have been reported. (L795)

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).